Thursday, January 1, 2026

Orthostatic Hypotension

A 72-year-old man presents after a brief loss of consciousness shortly after standing from bed. Before losing consciousness, he experienced lightheadedness, generalized weakness, and dimming of vision. There were no preceding palpitations, chest pain, prolonged tonic-clonic movements, or postictal confusion. He regained consciousness rapidly after lying flat. Cardiac and neurologic examinations are unremarkable. Supine blood pressure is 142/78 mm Hg with a heart rate of 70 beats per minute. After 3 minutes of standing, blood pressure falls to 110/64 mm Hg with a heart rate of 88 beats per minute, reproducing his typical lightheadedness. A 12-lead ECG shows normal sinus rhythm without significant abnormalities. Diagnosis?

Diagnosis is Syncope Due to Orthostatic Hypotension.

The patient has a sustained fall in systolic blood pressure of 32 mm Hg and diastolic blood pressure of 14 mm Hg within 3 minutes of standing, accompanied by typical orthostatic symptoms and a history of syncope immediately after standing.

1. Definition

Orthostatic hypotension (OH) is an abnormal, sustained fall in blood pressure after assuming the upright position.

Classic orthostatic hypotension is defined as a sustained fall within 3 minutes of standing or head-up tilt of:

  1. Systolic blood pressure ≥20 mm Hg

or

  1. Diastolic blood pressure ≥10 mm Hg

ESC guidance also considers a sustained fall in systolic blood pressure to <90 mm Hg abnormal in the appropriate clinical setting.

In patients with supine hypertension, a systolic blood pressure fall of ≥30 mm Hg may be a more appropriate threshold.

Syncope due to orthostatic hypotension occurs when the postural fall in arterial pressure causes transient global cerebral hypoperfusion, resulting in brief loss of consciousness with spontaneous complete recovery.

Importantly:

Orthostatic hypotension does not automatically mean that OH caused the syncope.

The diagnosis is strongest when the clinical event is related to standing and the documented orthostatic BP fall reproduces the patient's typical symptoms.

2. Pathophysiology

Standing causes gravitational redistribution of blood into the lower extremities and splanchnic circulation.

This reduces:

  1. Venous return
  2. Ventricular filling
  3. Stroke volume
  4. Arterial blood pressure

Normally, baroreflex activation produces:

  1. Sympathetic vasoconstriction
  2. Increased heart rate
  3. Increased cardiac contractility
  4. Venous constriction
  5. Skeletal muscle pump activation

These mechanisms maintain arterial pressure and cerebral perfusion.

Orthostatic hypotension develops when these compensatory mechanisms are inadequate because of:

  1. Volume depletion
  2. Medication effects
  3. Autonomic dysfunction
  4. Age-related impairment of cardiovascular compensation
  5. A combination of these factors

When arterial pressure falls sufficiently:

Orthostatic hypotension → cerebral hypoperfusion → presyncope or syncope

3. Types of Orthostatic Hypotension

3.1 Initial Orthostatic Hypotension

Occurs within approximately 15 seconds of standing.

Characterized by a transient fall of:

  1. SBP >40 mm Hg

and/or

  1. DBP >20 mm Hg

Symptoms may include:

  1. Immediate lightheadedness
  2. Visual dimming
  3. Weakness
  4. Unsteadiness
  5. Presyncope or syncope

Because the BP fall is brief, routine cuff measurements may miss it.

Continuous beat-to-beat blood pressure monitoring is required for formal documentation.

3.2 Classic Orthostatic Hypotension

Occurs within 3 minutes of standing.

Defined by:

SBP ↓ ≥20 mm Hg OR DBP ↓ ≥10 mm Hg

Common mechanisms include:

  1. Volume depletion
  2. Medication effects
  3. Autonomic dysfunction

3.3 Delayed Orthostatic Hypotension

Develops after more than 3 minutes of upright posture.

The BP usually falls gradually.

Consider delayed OH when:

  1. Symptoms are clearly related to prolonged standing
  2. Routine 3-minute orthostatic measurements are normal
  3. Symptoms develop only after several minutes upright

Prolonged standing assessment or tilt-table testing may be useful.

4. Causes

4.1 Volume Depletion

Important causes include:

  1. Hemorrhage
  2. Vomiting
  3. Diarrhea
  4. Poor oral intake
  5. Excessive sweating
  6. Diuretic-related volume loss

The compensatory heart-rate response is usually preserved or increased.

4.2 Medication-Related Orthostatic Hypotension

Common contributors include:

  1. Diuretics
  2. Alpha blockers
  3. Nitrates and other vasodilators
  4. Beta blockers in susceptible patients
  5. Central sympatholytic agents
  6. Tricyclic antidepressants
  7. Other psychoactive medications
  8. Dopaminergic medications

A complete medication review is essential.

Do not automatically discontinue all antihypertensive treatment because OH is present.

Identify potentially contributing drugs and optimize the regimen according to the patient's underlying indications, BP pattern, and cardiovascular risk.

4.3 Neurogenic Orthostatic Hypotension

Neurogenic OH results from impaired autonomic sympathetic vasoconstriction during standing.

Important causes include:

  1. Parkinson disease
  2. Multiple system atrophy
  3. Pure autonomic failure
  4. Diabetic autonomic neuropathy
  5. Amyloidosis
  6. Other autonomic neuropathies

Neurogenic OH is often sustained and reproducible and may coexist with supine hypertension.

5. Clinical Features

Symptoms typically occur while upright and improve after sitting or lying down.

Common manifestations include:

  1. Lightheadedness
  2. Visual dimming or blurred vision
  3. Generalized weakness
  4. Fatigue
  5. Unsteadiness
  6. Presyncope
  7. Syncope

Symptoms may be worse:

  1. On rising in the morning
  2. After prolonged standing
  3. After meals
  4. In hot environments
  5. After exercise
  6. During dehydration
  7. After medications that reduce BP

Rapid improvement after sitting or lying down supports an orthostatic mechanism.

6. Diagnostic Evaluation

6.1 Initial Evaluation

The core evaluation is:

HISTORY + PHYSICAL EXAMINATION + ORTHOSTATIC BP/HR + 12-LEAD ECG

Important questions include:

  1. Did the event occur during or shortly after standing?
  2. Was there lightheadedness, weakness, or visual dimming?
  3. Did symptoms improve after lying down?
  4. Was there vomiting, diarrhea, poor intake, or blood loss?
  5. Were medications recently started or increased?
  6. Are symptoms worse after meals or in the morning?
  7. Are there symptoms of autonomic dysfunction?
  8. Are there cardiac red flags?

6.2 Measuring Orthostatic Blood Pressure

A practical protocol is:

  1. Rest supine for 5 to 10 minutes
  2. Measure supine BP and heart rate
  3. Have the patient stand
  4. Repeat BP and heart rate during the first 3 minutes
  5. Record symptoms during testing

Measurements at approximately 1 and 3 minutes are clinically useful.

The key question is:

Does the BP fall reproduce the patient's typical symptoms?

6.3 Heart-Rate Response

The heart-rate response may help identify the mechanism but is supportive, not diagnostic.

Preserved or Exaggerated HR Increase

Favors:

  1. Volume depletion
  2. Hemorrhage
  3. Dehydration
  4. Other non-neurogenic aggravating factors

Blunted HR Increase

Supports:

Neurogenic orthostatic hypotension

A ΔHR/ΔSBP ratio <0.5 beats/min per mm Hg supports neurogenic OH.

Interpret heart rate cautiously in patients with:

  1. Beta-blocker therapy
  2. Other rate-limiting drugs
  3. Pacemakers
  4. Conduction disease
  5. Chronotropic incompetence

6.4 Targeted Testing

Additional testing should be guided by the clinical context.

CBC
→ suspected anemia or hemorrhage

Electrolytes and renal function
→ dehydration or medication effects

Glucose
→ suspected hypoglycemia

Troponin
→ suspected myocardial ischemia or injury

Echocardiography
→ suspected structural cardiac disease

Ambulatory ECG monitoring
→ suspected intermittent arrhythmia

Tilt-table testing
→ suspected delayed OH, reflex syncope, or unresolved orthostatic symptoms after nondiagnostic initial testing

Routine broad laboratory testing, neuroimaging, EEG, or carotid imaging is not indicated without a specific clinical reason.

7. Differential Diagnosis

7.1 Vasovagal Syncope

Features favoring vasovagal syncope include:

  1. Emotional or painful trigger
  2. Prolonged standing
  3. Warmth
  4. Nausea
  5. Diaphoresis
  6. Pallor

OH is favored by a sustained postural BP fall associated with typical symptoms.

Overlap can occur.

7.2 Cardiac Syncope

Do not attribute syncope to OH solely because orthostatic BP criteria are met.

Cardiac red flags include:

  1. Exertional syncope
  2. Supine syncope
  3. Abrupt syncope without prodrome
  4. Palpitations immediately before syncope
  5. Structural heart disease
  6. Abnormal ECG
  7. Family history of sudden cardiac death

These findings warrant urgent cardiac evaluation.

7.3 Seizure

Features favoring seizure include:

  1. Prolonged postictal confusion
  2. Lateral tongue biting
  3. Prolonged tonic-clonic activity
  4. Stereotyped epileptic aura

Brief myoclonic movements can occur during syncope and do not by themselves establish epilepsy.

7.4 Postural Orthostatic Tachycardia Syndrome

Orthostatic hypotension: an abnormal BP fall is the defining hemodynamic feature.

POTS: excessive orthostatic tachycardia occurs without orthostatic hypotension.

8. Management

Management should treat the underlying mechanism and symptoms, not simply normalize the standing BP.

8.1 Acute Management

When symptoms occur:

  1. Sit or lie down immediately
  2. Correct volume depletion
  3. Identify hemorrhage or another acute cause
  4. Review potentially responsible medications

For acute dehydration:

Oral or intravenous fluid resuscitation is appropriate.

If hemorrhage is present:

Identify and treat the bleeding source urgently.

8.2 Medication Review

For medication-related OH:

  1. Remove unnecessary contributing medications
  2. Reduce doses when appropriate
  3. Modify medication timing
  4. Substitute lower-risk agents when appropriate

The goal is to identify and modify culprit medications, not indiscriminately stop indicated cardiovascular therapy.

8.3 Nonpharmacologic Treatment

First-line measures include:

  1. Adequate hydration
  2. Appropriate sodium intake when not contraindicated
  3. Slow transition from lying to standing
  4. Avoid prolonged standing
  5. Avoid excessive heat
  6. Limit excessive alcohol intake
  7. Smaller meals when postprandial hypotension is problematic
  8. Physical counter-pressure maneuvers
  9. Compression therapy, particularly abdominal compression

Fluid and sodium intake should be individualized in patients with:

  1. Heart failure
  2. Chronic kidney disease
  3. Hypertension
  4. Supine hypertension

9. Pharmacologic Treatment of Neurogenic OH

Pharmacologic therapy is generally reserved for persistent symptomatic neurogenic OH despite correction of reversible causes and nonpharmacologic treatment.

9.1 Midodrine

Midodrine is an oral alpha-1 adrenergic agonist that increases peripheral vascular resistance and standing BP.

Important adverse effects include:

  1. Supine hypertension
  2. Piloerection
  3. Scalp paresthesia
  4. Urinary retention

9.2 Droxidopa

Droxidopa is a norepinephrine precursor used for symptomatic neurogenic OH.

Important adverse effects include:

  1. Supine hypertension
  2. Headache
  3. Dizziness
  4. Nausea

Midodrine and droxidopa are the two medications approved in the United States for symptomatic neurogenic OH.

9.3 Fludrocortisone

Fludrocortisone promotes sodium retention and expands plasma volume.

Its supporting evidence is weaker than that for midodrine or droxidopa.

Important adverse effects include:

  1. Supine hypertension
  2. Edema
  3. Hypokalemia
  4. Fluid retention

Fludrocortisone is contraindicated in heart failure and should be used cautiously, if at all, when significant supine hypertension is present.

10. Supine Hypertension

Neurogenic OH may coexist with:

ORTHOSTATIC HYPOTENSION WHILE UPRIGHT + HYPERTENSION WHILE SUPINE

This complicates treatment because therapies that improve standing BP may worsen supine hypertension.

Therefore:

  1. Monitor both standing and supine BP
  2. Avoid unnecessary late doses of pressor medications
  3. Individualize salt and fluid intake
  4. Review medication timing
  5. Consider ambulatory BP monitoring in selected patients

The treatment goal is:

Improve upright symptoms and cerebral perfusion while minimizing supine hypertension.

11. Key Clinical Insight

Orthostatic hypotension is a hemodynamic finding. Syncope due to orthostatic hypotension is a clinical diagnosis linking that BP fall to transient cerebral hypoperfusion and loss of consciousness.

The classic pattern is:

Standing + typical orthostatic symptoms + sustained SBP fall ≥20 mm Hg OR DBP fall ≥10 mm Hg within 3 minutes

Then identify the mechanism:

Volume depletion → restore volume and treat the cause

Medication-related OH → identify and modify contributing medications

Neurogenic OH → nonpharmacologic treatment first, followed by selected pharmacologic therapy when necessary

Heart-rate response may help:

Preserved or exaggerated HR increase → favors volume depletion or another non-neurogenic contributor

Inappropriately small HR increase → supports neurogenic autonomic dysfunction

Most importantly:

Do not diagnose syncope due to OH solely because orthostatic BP criteria are met. The relationship to standing, reproduction of typical symptoms, ECG, and competing causes must also be considered.

In this patient:

Syncope shortly after standing + typical orthostatic prodrome + rapid recovery + reproduction of symptoms with a sustained SBP fall ≥20 mm Hg OR DBP fall ≥10 mm Hg within 3 minutes = Syncope Due to Orthostatic Hypotension.

References

  1. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. European Heart Journal. 2018;39(21):1883-1948. doi:10.1093/eurheartj/ehy037. PMID: 29562304.
  2. Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope. Circulation. 2017;136(5):e60-e122. doi:10.1161/CIR.0000000000000499. PMID: 28280231.
  3. Juraschek SP, Cortez MM, Flack JM, et al. Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2024;81(3):e16-e30. doi:10.1161/HYP.0000000000000236. PMID: 38205630.

No comments:

Post a Comment